About ACXEL News Get in touch

ACXEL's digital microfluidic technology is based on the ubiquitous
large-area electronics platform, and committed to achieving a high degree
of integration and automation. The technology provides a means of executing
complex experimental procedures at the level of single cells and is used in
fundamental bio-related research, cell line development, cell threapy
development, synthetic biology and other scenarios. ACXEL's principal
technical team and its core technology, following more than ten years of
development, is from the Laboratory of Professor Arokia Nathan who was the
Chair of Photonic Systems and Displays, Department of Engineering,
University of Cambridge, UK, and the Suzhou Institute of Biomedical
Engineering and Technology, Chinese Academy of Sciences, China. The company
was spun out from the University of Cambridge and the Chinese Academy of
Sciences, by co-founders Dr. Hanbin Ma and Prof. Arokia Nathan, in the
Cambridge Science Park, UK in 2016, and subsequently relocated to Foshan
City, Guangdong Province, China in August 2020.